Veracyte, Inc. (VCYT) - מזומן למניה

סמל תאגידי ולוגו של veracyte.com (VCYT)

The cash per share of Veracyte, Inc. (VCYT) reflects the dynamics of a genomic analysis medical ecosystem deeply integrated into oncology centers, while 4.55 captures the current state of this parameter. The company's innovative tests eliminate unnecessary biopsies, optimizing costs for insurers. Expansion into European markets is driven by the strategic merger of acquired laboratories with organic business growth.

Veracyte (VCYT) - מזומנים למניה מ-04.07.2022 עד 20.11.2026

פילוחים אנליטיים של חברת Veracyte Diagnostics (VCYT)

- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח כללי של החברה:Veracyte Corp, VCYT
מוצר ממותג של Veracyte Corp

For Veracyte, Inc. (VCYT), which develops high-tech genomic diagnostics and AI tests, the cash per share history reflects the ability to fund expansion without external borrowing. This indicator is calculated by dividing total liquid assets by the number of shares outstanding, determining the actual cash cushion per share and confirming the company's fundamental stability during periods of market volatility.